Patents/Assignees

GUANGZHOU BIO-GENE TECHNOLOGY CO., Ltd

4 patents in portfolio

US12595308utility2026
Anti-b7h3 Antibody and Use Thereof
0 cites
US12508312utility2025
Chimeric Antigen Receptor Targeting CLL1 and Use Thereof
0 cites
US12358990utility2025
Anti-cll1 Antibody and Use Thereof
0 cites
US11542318utility2023
Use of Chemokine Receptor CXCR5
0 cites